Benzinga | Oct 18, 2021 09:33AM EDT

Wells Fargo Maintains Overweight on Medtronic, Lowers Price Target to $144

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and lowers the price target from $151 to $144.